Public-registry trials using OK-101 that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease | Okyo Pharma Ltd | Dry Eye Disease | PHASE2 | 6 |
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
